To help reduce opioid-related fatalities on college campuses, Padagis has committed to giving free Naloxone HCI Nasal Spray and funding to support End Overdose's 43 chapters on college campuses ALLEGAN, Mich. , Nov. 19, 2024 /PRNewswire/ -- According to recent data from the Centers for Disease Control and Prevention, overdose death rates have spiked dramatically for young adults, rising 34 percent in four years.
Padagis ®, a pharmaceutical company specializing in high-quality generic prescription (Rx) and over-the-counter (OTC) products, is working to reduce these alarming statistics and has donated 15,000 units of Padagis Naloxone HCl Nasal Spray, 4mg, a generic OTC nasal spray for emergency treatment of an opioid overdose, as well as a financial contribution to End Overdose . This contribution will help End Overdose effectively distribute Padagis Naloxone to thousands of college students and support 43 chapters on campuses across the U.S.
"We are thrilled to support and partner with End Overdose to help them on their mission to end drug-related overdose deaths through education, medical intervention and public awareness," said Pam Hoffman , President of Padagis. "At Padagis, we aim to reduce the stigma around the opioid epidemic and provide education and medication to reverse opioid overdoses quickly. Our hope with this donation is to educate college students about the dangers of opioids and help save lives by arming them with our Naloxone nasal spray.
" Padagis' OTC Naloxo.
